Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (the TRIUMPH Study)

NCT04925973 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT04925973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04925973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (the TRIUMPH Study)
Lead sponsor
McMaster University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 1, 2021
Completion date
December 31, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis acute